Thanks to everyone who joined us online for the first SynbiTECH Live webinar on Monday 6th July, especially our fantastic panel of speakers who shared their experiences and insights on the ongoing pandemic and the role of synbio.
Don't worry if you missed it, the webinar is now available to view in full below.
The coronavirus pandemic has had a devastating effect on international public health and the world economy. Our first SynbiTECH Live webinar addresses the role of synthetic biology in the detection and treatment of COVID-19 and its potential role in combatting future pandemics.
We review the ongoing pandemic from both UK and US standpoints, with insights from leading global experts in epidemiology, infectious diseases and vaccine technology. This is followed by an overview of the role of synthetic biology in the pandemic, how it has been effectively applied to testing for the virus, and its potential for the future.
We were joined by medical scientists and clinicians directly involved in the epidemic who will share their experiences and learnings from the last few months.
Introduction and webinar overview
15.00 – 15.05
Professors Paul Freemont and Richard Kitney, Co-Directors of SynbiCITE
Coronavirus global pandemic
15.05 – 15.20
Neil Ferguson, Vice-Dean, Imperial College London
Coronavirus in the US
15.20 – 15.35
Rick Johnson, CEO and Founder of Global Helix LLC
15.35 – 15.50
Professor Wendy Barclay, Action Medical Research Chair, Imperial College London
Overview of synthetic biology and its role
15.50 – 16.10
- DNA reading and writing
- The design, build, test and learn paradigm (DBTL)
- Systematic biodesign and the development of workflows
- The development of laboratory automation and biofoundries
The use of biofoundries and synthetic biology for testing
16.10 – 16.30
Paul Freemont and Michael Crone
- The role of biofoundries in national and international emergencies
- The advantage of synthetic biology-based automated workflows
- Repurposing automated workflows in the London Biofoundry for COVID-19 testing
- Reagent agnostic drop-in solutions to existing diagnostic workflows
- Novel NextGen CRISPR / LAMP workflows for COVID testing
16.30 – 16.45
Robin Shattock, Chair in Mucosal Infection and Immunity, Imperial College London
Discussion and conclusions
16.45 – 17.00
Paul Freemont and Richard Kitney